| 1 |
Singh TP, Hsich E, Cherikh WS, Perch M, Hayes D Jr, Lewis A, et al. The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: 2025 annual report of heart and lung transplantation. J Heart Lung Transplant. 2025; 44(12):1857-73.
|
| 2 |
Ul Abideen Z, Malik MS, Price AM, Ko E, Connor A. Cytomegalovirus reactivation in seropositive kidney transplant recipients: a retrospective analysis of a UK cohort. Exp Clin Transplant. 2024; 22(12): 915-20.
|
| 3 |
Schlaeffer-Yosef T, Nesher L. Tackling CMV in transplant recipients: past, present, and future. Infect Dis Ther. 2025; 14(6): 1183-200.
|
| 4 |
Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TMV, Campos SV, et al. Cytomegalovirus infection in transplant recipients. Clinics. 2015; 70(7): 515-23.
|
| 5 |
Mourad FH, Hashash JG, Kariyawasam VC, Leong RW. Ulcerative colitis and cytomegalovirus infection: from A to Z. J Crohns Colitis. 2020; 14(8): 1162-71.
|
| 6 |
Camprodon RAM, Jacob S, Malkawi A, Al-Ghnaniem R. CMV colitis presenting as acute abdomen requires early diagnosis and treatment to avoid mortality. Acta Chir Belg. 2007; 107(4): 378-81.
|
| 7 |
Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis. 2007; 13(12): 1516-21.
|
| 8 |
Durand CM, Marr KA, Arnold CA, Tang L, Durand DJ, Avery RK, et al. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis. 2013; 57(11): 1550-9.
|
| 9 |
Kredel LI, Mundt P, van Riesen L, Jöhrens K, Hofmann J, Loddenkemper C, et al. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study. Int J Colorectal Dis. 2019; 34(2): 229-37.
|
| 10 |
Jiang YZ, Zhou GP, Wei L, Qu W, Zeng ZG, Liu Y, et al. Long-term clinical outcomes and health-related quality of life in patients with isolated methylmalonic acidemia after liver transplantation: experience from the largest cohort study in China. World J Pediatr. 2024; 20(8):809-21.
|
| 11 |
Boignard A, Augier C, Kheng M, Epaulard O, Germi R. Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients. Antivir Ther. 2022; 27(6): 13596535221133619.
|
| 12 |
Saldan A, Mengoli C, Sgarabotto D, Fedrigo M, Angelini A, Feltrin G, et al. Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients. Front Immunol. 2023; 14: 1171197.
|
| 13 |
Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019; 29(3): e2034.
|
| 14 |
Lai CH, Cao K, Ong G, Naim M, Wang Q, Mirocha J, et al. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation. 2011; 92(1): 48-53.
|
), Sheng Liu1(
